LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 39 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $63,000 | -97.2% | 65 | -97.2% | 0.00% | -97.4% |
| Q1 2022 | $2,245,000 | -90.5% | 2,304 | -89.9% | 0.15% | -94.6% |
| Q2 2021 | $23,719,000 | 0.0% | 22,751 | 0.0% | 2.84% | 0.0% |
| Q1 2021 | $23,719,000 | +57.5% | 22,751 | +47.1% | 2.84% | +226.5% |
| Q4 2020 | $15,056,000 | +235.8% | 15,462 | +235.2% | 0.87% | +75.3% |
| Q3 2020 | $4,483,000 | +70.3% | 4,613 | +60.5% | 0.50% | +57.3% |
| Q2 2020 | $2,633,000 | +125.6% | 2,874 | +132.3% | 0.32% | +130.7% |
| Q1 2020 | $1,167,000 | – | 1,237 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 64,118,000 | $55,709,000 | 4.91% |
| SYMPHONY ASSET MANAGEMENT LLC | 9,000,000 | $7,790,000 | 1.72% |
| CANYON CAPITAL ADVISORS LLC | 65,000,000 | $56,160,000 | 1.31% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,450,000 | $38,362,000 | 1.24% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 60,954,000 | $52,832,000 | 1.02% |
| Context Capital Management, LLC | 2,350,000 | $2,028,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,160,000 | $3,622,000 | 0.47% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,418,000 | 0.44% |
| OAKTREE CAPITAL MANAGEMENT LP | 23,903,000 | $20,688,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 36,633,000 | $31,784,000 | 0.37% |